标题
Emerging drugs on methicillin-resistantStaphylococcus aureus
作者
关键词
-
出版物
EXPERT OPINION ON EMERGING DRUGS
Volume 18, Issue 3, Pages 291-305
出版商
Informa Healthcare
发表日期
2013-07-13
DOI
10.1517/14728214.2013.813480
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Community-associated methicillin-resistant Staphylococcus aureus: prevalence in skin and soft tissue infections at emergency departments in the Greater Toronto Area and associated risk factors
- (2016) Heather J. Adam et al. Canadian Journal of Emergency Medicine
- Comparative Analysis of the Antibacterial Activity of a Novel Peptide Deformylase Inhibitor, GSK1322322
- (2013) Karen O'Dwyer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Epidemics of Community-Associated Methicillin-Resistant Staphylococcus aureus in the United States: A Meta-Analysis
- (2013) Vanja M. Dukic et al. PLoS One
- In VitroActivity and Microbiological Efficacy of Tedizolid (TR-700) against Gram-Positive Clinical Isolates from a Phase 2 Study of Oral Tedizolid Phosphate (TR-701) in Patients with Complicated Skin and Skin Structure Infections
- (2012) Philippe Prokocimer et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oritavancin Microbiologic Features and Activity Results From the Surveillance Program in the United States
- (2012) Rodrigo E. Mendes et al. CLINICAL INFECTIOUS DISEASES
- Linezolid in Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia: A Randomized, Controlled Study
- (2012) R. G. Wunderink et al. CLINICAL INFECTIOUS DISEASES
- Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials
- (2012) P. Prasad et al. CLINICAL INFECTIOUS DISEASES
- Bacterial Cell Wall Compounds as Promising Targets of Antimicrobial Agents II. Immunological and Clinical Aspects
- (2012) Tobias Schuerholz et al. CURRENT DRUG TARGETS
- New therapy options for MRSA with respiratory infection/pneumonia
- (2012) Paula Ramirez et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Tedizolid (TR-701): a new oxazolidinone with enhanced potency
- (2012) Zeina A. Kanafani et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The oxazolidinones: past, present, and future
- (2011) Karen Joy Shaw et al. Annals of the New York Academy of Sciences
- Pharmacokinetic/Pharmacodynamic (PK/PD) Indices of Antibiotics Predicted by a Semimechanistic PKPD Model: a Step toward Model-Based Dose Optimization
- (2011) Elisabet I. Nielsen et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In VitroCross-Resistance to Daptomycin and Host Defense Cationic Antimicrobial Peptides in Clinical Methicillin-Resistant Staphylococcus aureus Isolates
- (2011) Nagendra N. Mishra et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of the Efficacy and Safety of Oritavancin Front-Loaded Dosing Regimens to Daily Dosing: an Analysis of the SIMPLIFI Trial
- (2011) Lala M. Dunbar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- Efficacy of linezolid compared to vancomycin in an experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated pigs*
- (2011) Pilar Martinez-Olondris et al. CRITICAL CARE MEDICINE
- Metabolic basis for the differential susceptibility of Gram-positive pathogens to fatty acid synthesis inhibitors
- (2011) J. B. Parsons et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comparative In Vitro Activities of Nemonoxacin (TG-873870), a Novel Nonfluorinated Quinolone, and Other Quinolones against Clinical Isolates
- (2010) T.-L. Lauderdale et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The 10 × ‘20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020
- (2010) CLINICAL INFECTIOUS DISEASES
- Not Community-Associated Methicillin-Resistant Staphylococcus aureus (CA-MRSA)! A Clinician's Guide to Community MRSA - Its Evolving Antimicrobial Resistance and Implications for Therapy
- (2010) K. Chua et al. CLINICAL INFECTIOUS DISEASES
- Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia
- (2010) Antonio T. Freire et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- New Lipoglycopeptides
- (2010) George G. Zhanel et al. DRUGS
- Antimicrobial treatment of nosocomial meticillin-resistant Staphylococcus aureus (MRSA) pneumonia: current and future options
- (2010) Tobias Welte et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Clinical Outbreak of Linezolid-Resistant Staphylococcus aureus in an Intensive Care Unit
- (2010) Miguel Sánchez García JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Activity of quinupristin/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes
- (2010) Pierre Baudoux et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Essentiality of FASII pathway for Staphylococcus aureus
- (2010) Wendy Balemans et al. NATURE
- Current and novel antibiotics against resistant Gram-positive bacteria
- (2010) Federico Perez Infection and Drug Resistance
- Iclaprim, a Novel Diaminopyrimidine for the Treatment of Resistant Gram-Positive Infections
- (2009) Carrie A Sincak et al. ANNALS OF PHARMACOTHERAPY
- Multicenter, Randomized Study of the Efficacy and Safety of Intravenous Iclaprim in Complicated Skin and Skin Structure Infections
- (2009) D. Krievins et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Potency and Bactericidal Activity of Iclaprim against Recent Clinical Gram-Positive Isolates
- (2009) H. S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oritavancin Population Pharmacokinetics in Healthy Subjects and Patients with Complicated Skin and Skin Structure Infections or Bacteremia
- (2009) C. M. Rubino et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prospective Comparison of the Clinical Impacts of Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Susceptible MRSA
- (2009) K. C. Horne et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inappropriate therapy for methicillin-resistant Staphylococcus aureus: Resource utilization and cost implications*
- (2009) Andrew F. Shorr et al. CRITICAL CARE MEDICINE
- Productive steps toward an antimicrobial targeting virulence
- (2009) Amy K Barczak et al. CURRENT OPINION IN MICROBIOLOGY
- What is MRSA?
- (2009) A. Pantosti et al. EUROPEAN RESPIRATORY JOURNAL
- The role of telavancin in the treatment of MRSA infections in hospital
- (2009) Matteo Bassetti et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Lack of community-associated MRSA in Rome
- (2009) G.B. Orsi et al. JOURNAL OF HOSPITAL INFECTION
- Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens
- (2009) Sophie Brinster et al. NATURE
- Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists
- (2008) M. Rybak et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- In Vitro Profiling of Ceftaroline against a Collection of Recent Bacterial Clinical Isolates from across the United States
- (2008) Y. Ge et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Antimicrobial Activities of Ceftaroline and ME1036 Tested against Clinical Strains of Community-Acquired Methicillin-Resistant Staphylococcus aureus
- (2008) H. S. Sader et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Relationship between Vancomycin MIC and Failure among Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin
- (2008) T. P. Lodise et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Larger Vancomycin Doses (at Least Four Grams per Day) Are Associated with an Increased Incidence of Nephrotoxicity
- (2008) T. P. Lodise et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dalbavancin: a Novel Once-Weekly Lipoglycopeptide Antibiotic
- (2008) L. D. Saravolatz et al. CLINICAL INFECTIOUS DISEASES
- Telavancin Versus Vancomycin for the Treatment of Complicated Skin and Skin‐Structure Infections Caused by Gram‐Positive Organisms
- (2008) Martin E. Stryjewski et al. CLINICAL INFECTIOUS DISEASES
- Complicated Skin and Skin‐Structure Infections and Catheter‐Related Bloodstream Infections: Noninferiority of Linezolid in a Phase 3 Study
- (2008) Mark H. Wilcox et al. CLINICAL INFECTIOUS DISEASES
- Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp.
- (2008) S. Roveta et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pleiotropic Roles of Polyglycerolphosphate Synthase of Lipoteichoic Acid in Growth of Staphylococcus aureus Cells
- (2008) Y. Oku et al. JOURNAL OF BACTERIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started